CV Sciences, Inc. SEC filings CVSI

CV Sciences, Inc. has 431 filings in SEC EDGAR's recent list, going back to Jan 31, 2011. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 26, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Apr 4, 2022 Dec 31, 2021
10-K Annual report Mar 19, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 30, 2018 Dec 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
10-K Annual report Apr 14, 2016 Dec 31, 2015
10-K Annual report Mar 31, 2015 Dec 31, 2014
10-K Annual report Mar 28, 2014 Dec 31, 2013
10-K Annual report Apr 16, 2013 Dec 31, 2012
10-K Annual report Apr 10, 2012 Dec 31, 2011

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CVSI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1510964
Former names
CannaVEST Corp. (until Jan 4, 2016); Foreclosure Solutions, Inc. (until Nov 30, 2012)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.